2014
DOI: 10.5935/abc.2014s005
|View full text |Cite|
|
Sign up to set email alerts
|

I Diretriz de Insuficiência Cardíaca (IC) e Transplante Cardíaco, no Feto, na Criança e em Adultos com Cardiopatia Congênita, da Sociedade Brasileira de Cardiologia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
10
0
16

Year Published

2015
2015
2018
2018

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(26 citation statements)
references
References 0 publications
0
10
0
16
Order By: Relevance
“…(1,2) In an attempt to minimize the situation, heart transplantation is a surgical alternative used to treat heart failure not responsive to clinical and/or outpatient treatment, improving the expectancy and quality of life of patients suffering from this disease. (2) However, the survival rate after heart transplantation decreases as the years since the procedure go by, and this rate suffers the influence of the post-surgery monitoring of patients.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…(1,2) In an attempt to minimize the situation, heart transplantation is a surgical alternative used to treat heart failure not responsive to clinical and/or outpatient treatment, improving the expectancy and quality of life of patients suffering from this disease. (2) However, the survival rate after heart transplantation decreases as the years since the procedure go by, and this rate suffers the influence of the post-surgery monitoring of patients.…”
Section: Introductionmentioning
confidence: 99%
“…(1,2) In an attempt to minimize the situation, heart transplantation is a surgical alternative used to treat heart failure not responsive to clinical and/or outpatient treatment, improving the expectancy and quality of life of patients suffering from this disease. (2) However, the survival rate after heart transplantation decreases as the years since the procedure go by, and this rate suffers the influence of the post-surgery monitoring of patients. Hence, heart transportation outpatient care plays an important role in the maintenance of the well-being of heart transplantation patients, favoring longer survival time with better quality of life, which is correlated to the absence of heart failure symptoms that allows resuming basic and instrumental activities of daily living and a potential return to labor activities.…”
Section: Introductionmentioning
confidence: 99%
“…7,18,19 Cardiotoxicity related to cancer treatment may become manifest at any time, with reports of it occurring within 45 years or more after the end of treatment. 11,20,21 Theoretically, any chemotherapy has the potential to cause toxicity. 7 The main chemotherapeutic agents that present cardiotoxicity include anthracyclines (such as doxorubicin, epirubicin, and idarubicin), alkylating agents (cyclophosphamide and ifosfamide), antimicrotubule agents (such as paclitaxel and docetaxel), monoclonal antibodies (such as trastuzumab, bevacizumab), and tyrosine kinase inhibitor (such as sunitinib).…”
Section: Introductionmentioning
confidence: 99%
“…For children with a survival expectancy of less than two years, and after exhausting conservative therapies, heart transplants are recommended [4].…”
Section: Introductionmentioning
confidence: 99%